摘要
目的探讨异基因造血干细胞移植治疗白血病。方法脐血移植治疗儿童白血病3例,异基因外周血造血干细胞移植治疗白血病3例。结果6例患者完全植入,+15~+25天白细胞(WBC)>1.0×109/L,+35天~+51天血小板(Plt)>20×109/L。例1出现急性GVHDⅠ度,例5出现急性GVHDⅣ度,例6出现肝静脉闭塞综合征(VOD)、急性GVHDⅠ度、出血性膀胱炎(HC),例2移植后6个月复发,放弃治疗死亡。余5例正常生活或工作。结论异基因造血干细胞移植治疗白血病是安全有效的方法。
Objective To investigate the application of allogeneic hematopoietic stem cell transplantation in the treatment of leukemia. Methods Three children with leukemia received unrelated umbilical cord blood transplantation(UBCT). Three patient with leukemia received allogenic peripheral blood stem cell transplantation(PBSCT). Results Hematopoietic function recovered to〉1.0×10^9/L of leukocyte on 15-25 days and to 〉20×10^9/L of platelet on 35-51 days in all patients. Case 1 had developed grades-Ⅰ GVHD. Grades-Ⅳ GVHD occurred in case 5. Case 6 had developed VOD, grades-Ⅰ GVHD, HC. Case 2 died of replase at six months after transplantation, the others are surviving. Conclusion Allogeneic hematopoietic stem cell transplantation(HSCT) is an effective and safe treatment for leukemia.
出处
《白血病.淋巴瘤》
CAS
2005年第4期224-227,共4页
Journal of Leukemia & Lymphoma
关键词
白血病
造血干细胞移植
移植物抗宿主病
Leukemia
Hematopoietic stem cell transplantation
Graft-venus-host-disease